Wells Fargo’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.5K | Sell |
11,800
-1,330
| -10% | -$4.56K | ﹤0.01% | 5161 |
|
|
2025
Q1 | $29.3K | Hold |
13,130
| – | – | ﹤0.01% | 5128 |
|
|
2024
Q4 | $38.5K | Buy |
13,130
+250
| +2% | +$733 | ﹤0.01% | 5078 |
|
|
2024
Q3 | $33.5K | Sell |
12,880
-2,800
| -18% | -$7.28K | ﹤0.01% | 5093 |
|
|
2024
Q2 | $46.4K | Sell |
15,680
-12,436
| -44% | -$36.8K | ﹤0.01% | 4957 |
|
|
2024
Q1 | $127K | Sell |
28,116
-2,200
| -7% | -$9.97K | ﹤0.01% | 4384 |
|
|
2023
Q4 | $173K | Sell |
30,316
-6,525
| -18% | -$37.3K | ﹤0.01% | 4160 |
|
|
2023
Q3 | $169K | Sell |
36,841
-75,139
| -67% | -$346K | ﹤0.01% | 4146 |
|
|
2023
Q2 | $723K | Sell |
111,980
-31,156
| -22% | -$201K | ﹤0.01% | 3485 |
|
|
2023
Q1 | $1.08M | Buy |
143,136
+58,806
| +70% | +$443K | ﹤0.01% | 3109 |
|
|
2022
Q4 | $854K | Buy |
84,330
+7,441
| +10% | +$75.4K | ﹤0.01% | 3141 |
|
|
2022
Q3 | $760K | Buy |
76,889
+3,798
| +5% | +$37.5K | ﹤0.01% | 3201 |
|
|
2022
Q2 | $778K | Buy |
73,091
+10,040
| +16% | +$107K | ﹤0.01% | 3260 |
|
|
2022
Q1 | $615K | Sell |
63,051
-29,132
| -32% | -$284K | ﹤0.01% | 4004 |
|
|
2021
Q4 | $1.32M | Sell |
92,183
-54,208
| -37% | -$776K | ﹤0.01% | 3632 |
|
|
2021
Q3 | $2.93M | Buy |
146,391
+95,669
| +189% | +$1.92M | ﹤0.01% | 3187 |
|
|
2021
Q2 | $1.12M | Sell |
50,722
-24,950
| -33% | -$549K | ﹤0.01% | 3916 |
|
|
2021
Q1 | $2.57M | Buy |
75,672
+75,472
| +37,736% | +$2.56M | ﹤0.01% | 3285 |
|
|
2020
Q4 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 5778 |
|